Big cap premarket losers led by NVS headlines
Premarket: NVS -13% after Phase 3 drug-failure headlines; Dyn -25%, IONS -10%, SRPT -9%, BIDU -7.5%, RPRX -6%, AMGN -5.5%, and PTON -4.5% also fall.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.